Epidemiology

You have full text access to this OnlineOpen article

Diabetes mellitus and risk of breast cancer: A meta-analysis

  1. Susanna C. Larsson1,†,*,
  2. Christos S. Mantzoros2,
  3. Alicja Wolk1

Article first published online: 30 MAR 2007

DOI: 10.1002/ijc.22717

Issue

International Journal of Cancer

International Journal of Cancer

Volume 121, Issue 4, pages 856–862, 15 August 2007

Additional Information

How to Cite

Larsson, S. C., Mantzoros, C. S. and Wolk, A. (2007), Diabetes mellitus and risk of breast cancer: A meta-analysis. Int. J. Cancer, 121: 856–862. doi: 10.1002/ijc.22717

Author Information

  1. 1

    Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

  2. 2

    Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

  1. †

    Fax: +46-8-304571.

*Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Box 210, SE-171 77 Stockholm, Sweden

Publication History

  1. Issue published online: 22 JUN 2007
  2. Article first published online: 30 MAR 2007
  3. Manuscript Accepted: 26 FEB 2007
  4. Manuscript Received: 3 JAN 2007

Funded by

  • The Swedish Cancer Society

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (190K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Konstantinos N. Aronis, Christos S. Mantzoros, A brief history of insulin resistance: from the first insulin radioimmunoassay to selectively targeting protein kinase C pathways, Metabolism, 2012, 61, 4, 445

    CrossRef

  2. 2
    Lorraine L. Lipscombe, Hadas D. Fischer, Lingsong Yun, Andrea Gruneir, Peter Austin, Lawrence Paszat, Geoff M. Anderson, Paula A. Rochon, Association between tamoxifen treatment and diabetes, Cancer, 2012, 118, 10
    Direct Link:
  3. 3
    T L Jørgensen, J Hallas, S Friis, J Herrstedt, Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality, British Journal of Cancer, 2012, 106, 7, 1353

    CrossRef

  4. 4
    J. A. Johnson, B. Carstensen, D. Witte, S. L. Bowker, L. Lipscombe, A. G. Renehan, Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence, Diabetologia, 2012, 55, 6, 1607

    CrossRef

  5. 5
    Adedayo A. Onitilo, Jessica M. Engel, Ingrid Glurich, Rachel V. Stankowski, Gail M. Williams, Suhail A. Doi, Diabetes and cancer I: risk, survival, and implications for screening, Cancer Causes & Control, 2012, 23, 6, 967

    CrossRef

  6. 6
    Cristina Bosetti, Valentina Rosato, Jerry Polesel, Fabio Levi, Renato Talamini, Maurizio Montella, Eva Negri, Alessandra Tavani, Antonella Zucchetto, Silvia Franceschi, Giovanni Corrao, Carlo La Vecchia, Diabetes Mellitus and Cancer Risk in a Network of Case-Control Studies, Nutrition and Cancer, 2012, 120420081609003

    CrossRef

  7. 7
    E. Fröhlich, R. Wahl, Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types?, Diabetes, Obesity and Metabolism, 2012, 14, 3
    Direct Link:
  8. 8
    Juhua Luo, Yea-Jyh Chen, Li-Jung Chang, Fasting blood glucose level and prognosis in non-small cell lung cancer (NSCLC) patients, Lung Cancer, 2012, 76, 2, 242

    CrossRef

  9. 9
    Corinne E. Joshu, Anna E. Prizment, Paul J. Dluzniewski, Andy Menke, Aaron R. Folsom, Josef Coresh, Hsin C. Yeh, Frederick L. Brancati, Elizabeth A. Platz, Elizabeth Selvin, Glycated hemoglobin and cancer incidence and mortality in the atherosclerosis in communities (ARIC) study, 1990–2006, International Journal of Cancer, 2012, 131, 3
    Direct Link:
  10. 10
    S. Sieri, V. Pala, F. Brighenti, C. Agnoli, S. Grioni, F. Berrino, F. Scazzina, D. Palli, G. Masala, P. Vineis, C. Sacerdote, R. Tumino, M.C. Giurdanella, A. Mattiello, S. Panico, V. Krogh, High glycemic diet and breast cancer occurrence in the Italian EPIC cohort, Nutrition, Metabolism and Cardiovascular Diseases, 2012,

    CrossRef

  11. 11
    Bing Pan, Hui Ren, Yijing Ma, Donghui Liu, Baoqi Yu, Liang Ji, Ling Pan, Jing Li, Liangui Yang, Xiaofeng Lv, Xiaoli Shen, Bin Chen, Youyi Zhang, Belinda Willard, Yubin He, Lemin Zheng, High-density lipoprotein of patients with type 2 diabetes mellitus elevates the capability of promoting migration and invasion of breast cancer cells, International Journal of Cancer, 2012, 131, 1
    Direct Link:
  12. 12
    Andrew A. Davis, Virginia G. Kaklamani, Metabolic Syndrome and Triple-Negative Breast Cancer: A New Paradigm, International Journal of Breast Cancer, 2012, 2012, 1

    CrossRef

  13. 13
    Ahmad Aljada, Shaker A. Mousa, Metformin and neoplasia: Implications and indications, Pharmacology & Therapeutics, 2012, 133, 1, 108

    CrossRef

  14. 14
    R. J. O. Dowling, S. Niraula, V. Stambolic, P. J. Goodwin, Metformin in cancer: translational challenges, Journal of Molecular Endocrinology, 2012, 48, 3, R31

    CrossRef

  15. 15
    Sui-Foon Lo, Shih-Ni Chang, Chih-Hsin Muo, Shih-Yin Chen, Fang-Yin Liao, Shu-Wei Dee, Pei-Chun Chen, Fung-Chang Sung, Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients, International Journal of Cancer, 2012, 131, 3
    Direct Link:
  16. 16
    Alessandro Antonelli, Nicola Arrighi, Serena Corti, Tiziano Zanotelli, Alberto Cozzoli, Sergio Cosciani Cunico, Claudio Simeone, Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: A single-center retrospective study, Urologic Oncology: Seminars and Original Investigations, 2012,

    CrossRef

  17. 17
    Sabina Sieri, Paola Muti, Agnoli Claudia, Franco Berrino, Valeria Pala, Sara Grioni, Carlo Alberto Abagnato, Giovanni Blandino, Paolo Contiero, Holger J. Schunemann, Vittorio Krogh, Prospective study on the role of glucose metabolism in breast cancer occurrence, International Journal of Cancer, 2012, 130, 4
    Direct Link:
  18. 18
    Ngwana Geraldine, Aerts Marc, Truyers Carla, Mathieu Chantal, Bartholomeeusen Stefaan, Wami Welcome, Buntinx Frank, Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting, Diabetes Research and Clinical Practice, 2012,

    CrossRef

  19. 19
    Hiroshi Noto, Tetsuro Tsujimoto, Mitsuhiko Noda, Significantly increased risk of cancer in diabetes mellitus patients: A meta-analysis of epidemiological evidence in Asians and non-Asians, Journal of Diabetes Investigation, 2012, 3, 1
    Direct Link:
  20. 20
    Matthew P. Ablett, Jagdeep K. Singh, Robert B. Clarke, Stem cells in breast tumours: Are they ready for the clinic?, European Journal of Cancer, 2012,

    CrossRef

  21. 21
    Mei-Yueh Lee, Kun-Der Lin, Pi-Jung Hsiao, Shyi-Jang Shin, The association of diabetes mellitus with liver, colon, lung, and prostate cancer is independent of hypertension, hyperlipidemia, and gout in Taiwanese patients, Metabolism, 2012, 61, 2, 242

    CrossRef

  22. 22
    Marcus Lind, Martin Fahlén, Björn Eliasson, Anders Odén, The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes, Primary Care Diabetes, 2012, 6, 1, 53

    CrossRef

  23. 23
    G. Wong, S. Zoungas, S. Lo, J. Chalmers, A. Cass, B. Neal, M. Woodward, V. Perkovic, P. Glasziou, B. Williams, K. Howard, J. R. Chapman, J. C. Craig, The risk of cancer in people with diabetes and chronic kidney disease, Nephrology Dialysis Transplantation, 2012,

    CrossRef

  24. 24
    Junlin Jiang, Meiling Yan, Jawahar L. Mehta, Changping Hu, Angiogenesis is a Link Between Atherosclerosis and Tumorigenesis: Role of LOX-1, Cardiovascular Drugs and Therapy, 2011, 25, 5, 461

    CrossRef

  25. 25
    Amy Guppy, Mariam Jamal-Hanjani, Lisa Pickering, Anticancer effects of metformin and its potential use as a therapeutic agent for breast cancer, Future Oncology, 2011, 7, 6, 727

    CrossRef

  26. 26
    M. Riihimaki, H. Thomsen, A. Brandt, J. Sundquist, K. Hemminki, Death causes in breast cancer patients, Annals of Oncology, 2011, 23, 3, 604

    CrossRef

  27. 27
    András Rosta, Diabetes és rákkockázat az onkológus szemszögéből, Orvosi Hetilap, 2011, 152, 29, 1144

    CrossRef

  28. You have free access to this content28
    Louise Bordeleau, Lorraine Lipscombe, Jan Lubinski, Parviz Ghadirian, William D. Foulkes, Susan Neuhausen, Peter Ainsworth, Michael Pollak, Ping Sun, Steven A. Narod, Diabetes and breast cancer among women with BRCA1 and BRCA2 mutations, Cancer, 2011, 117, 9
    Direct Link:
  29. 29
    S. C. Larsson, A. Wolk, Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies, Diabetologia, 2011, 54, 5, 1013

    CrossRef

  30. 30
    Carlo La Vecchia, Diabetes mellitus, medications for type 2 diabetes mellitus, and cancer risk, Metabolism, 2011, 60, 10, 1357

    CrossRef

  31. You have free access to this content31
    Emily Jane Gallagher, Derek LeRoith, Diabetes, cancer, and metformin: connections of metabolism and cell proliferation, Annals of the New York Academy of Sciences, 2011, 1243, 1
    Direct Link:
  32. 32
    Gabriel Chodick, Inbar Zucker, Diabetes, gestational diabetes and the risk of cancer in women: epidemiologic evidence and possible biologic mechanisms, Women's Health, 2011, 7, 2, 227

    CrossRef

  33. 33
    Jia-Yi Dong, Li-Qiang Qin, Dietary glycemic index, glycemic load, and risk of breast cancer: meta-analysis of prospective cohort studies, Breast Cancer Research and Treatment, 2011, 126, 2, 287

    CrossRef

  34. 34
    Linda G Mellbin, Klas Malmberg, Lars Rydén, Effects of glucose-lowering drugs in patients with diabetes and myocardial infarction, Diabetes Management, 2011, 1, 3, 281

    CrossRef

  35. 35
    M. Barba, F. Sperati, S. Stranges, C. Carlomagno, G. Nasti, V. Iaffaioli, G. Caolo, M. Mottolese, G. Botti, I. Terrenato, P. Vici, D. Serpico, A. Giordano, G. D'Aiuto, A. Crispo, M. Montella, G. Capurso, G. Delle Fave, B. Fuhrman, C. Botti, S. De Placido, Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort, Annals of Oncology, 2011,

    CrossRef

  36. 36
    Paweł Piątkiewicz, Anna Czech, Glucose Metabolism Disorders and the Risk of Cancer, Archivum Immunologiae et Therapiae Experimentalis, 2011, 59, 3, 215

    CrossRef

  37. 37
    Vimal Pandey, Balkrishna Chaube, Manoj Kumar Bhat, Hyperglycemia regulates MDR-1, drug accumulation and ROS levels causing increased toxicity of carboplatin and 5-fluorouracil in MCF-7 cells, Journal of Cellular Biochemistry, 2011, 112, 10
    Direct Link:
  38. 38
    Eu Chang Hwang, Young Jung Kim, In Sang Hwang, Jun Eul Hwang, Seung Il Jung, Dong Deuk Kwon, Kwangsung Park, Soo Bang Ryu, Impact of diabetes mellitus on recurrence and progression in patients with non-muscle invasive bladder carcinoma: A retrospective cohort study, International Journal of Urology, 2011, 18, 11
    Direct Link:
  39. 39
    Mats Lambe, Annette Wigertz, Hans Garmo, Göran Walldius, Ingmar Jungner, Niklas Hammar, Impaired glucose metabolism and diabetes and the risk of breast, endometrial, and ovarian cancer, Cancer Causes & Control, 2011, 22, 8, 1163

    CrossRef

  40. 40
    Jung Tak Park, Tae-Hyun Yoo, Tae Ik Chang, Dong Hyung Lee, Joo Hyun Lee, Jung Eun Lee, Hoon Young Choi, Shin-Wook Kang, Dae-Suk Han, Dong-Ryeol Ryu, Insulin resistance and lower plasma adiponectin increase malignancy risk in nondiabetic continuous ambulatory peritoneal dialysis patients, Metabolism, 2011, 60, 1, 121

    CrossRef

  41. 41
    V. Rosato, C. Bosetti, R. Talamini, F. Levi, M. Montella, A. Giacosa, E. Negri, C. La Vecchia, Metabolic syndrome and the risk of breast cancer in postmenopausal women, Annals of Oncology, 2011, 22, 12, 2687

    CrossRef

  42. 42
    Pamela J. Goodwin, Vuk Stambolic, Obesity and insulin resistance in breast cancer – Chemoprevention strategies with a focus on metformin, The Breast, 2011, 20, S31

    CrossRef

  43. 43
    R. Ruiter, L. E. Visser, M. P. P. Herk-Sukel, J. W. W. Coebergh, H. R. Haak, P. H. Geelhoed-Duijvestijn, S. M. J. M. Straus, R. M. C. Herings, B. H. Ch. Stricker, Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study, Diabetologia, 2011, 55, 1, 51

    CrossRef

  44. 44
    Hiroshi Noto, Tetsuro Tsujimoto, Takehiko Sasazuki, Mitsuhiko Noda, Significantly Increased Risk of Cancer in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis, Endocrine Practice, 2011, 17, 4, 616

    CrossRef

  45. 45
    Jean Grisouard, Kaethi Dembinski, Doris Mayer, Ulrich Keller, Beat Müller, Mirjam Christ-Crain, Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation, Diabetology & Metabolic Syndrome, 2011, 3, 1, 16

    CrossRef

  46. 46
    Evanthia Gouveri, Nikolaos Papanas, Efstratios Maltezos, The female breast and diabetes, The Breast, 2011, 20, 3, 205

    CrossRef

  47. 47
    E. J. King, H. Haboubi, D. Evans, I. Baker, S. C. Bain, J. W. Stephens, The management of diabetes in terminal illness related to cancer, QJM, 2011, 105, 1, 3

    CrossRef

  48. 48
    Abigail S Caudle, Kelly K Hunt, The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore, Current Opinion in Obstetrics and Gynecology, 2011, 23, 1, 31

    CrossRef

  49. 49
    Virginia Kaklamani, Nengjun Yi, Maureen Sadim, Kalliopi Siziopikou, Kui Zhang, Yanfei Xu, Sarah Tofilon, Surbhi Agarwal, Boris Pasche, Christos Mantzoros, The role of the fat mass and obesity associated gene (FTO) in breast cancer risk, BMC Medical Genetics, 2011, 12, 1, 52

    CrossRef

  50. 50
    J. A. Johnson, S. L. Bowker, K. Richardson, C. A. Marra, Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias, Diabetologia, 2011, 54, 9, 2263

    CrossRef

  51. 51
    Dorothee M. Baur, Jens Klotsche, Ole-Petter R. Hamnvik, Caroline Sievers, Lars Pieper, Hans-Ulrich Wittchen, Günter K. Stalla, Roland M. Schmid, Stefanos N. Kales, Christos S. Mantzoros, Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort, Metabolism, 2011, 60, 10, 1363

    CrossRef

  52. 52
    Lola B. Chambless, Scott L. Parker, Laila Hassam-Malani, Matthew J. McGirt, Reid C. Thompson, Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high-grade glioma, Journal of Neuro-Oncology, 2011, 106, 2, 383

    CrossRef

  53. 53
    Muhammet Ali Kaplan, Zafer Pekkolay, Mehmet Kucukoner, Ali Ä°nal, Zuhat Urakci, Hamza Ertugrul, Recai Akdogan, Ugur Firat, Ä°smail Yildiz, Abdurrahman Isikdogan, Type 2 diabetes mellitus and prognosis in early stage breast cancer women, Medical Oncology, 2011,

    CrossRef

  54. 54
    Shailesh Nandish, Oscar Bailon, Jamison Wyatt, John Smith, Adrienne Stevens, Mike Lujan, Robert Chilton, Vasculotoxic Effects of Insulin and Its Role in Atherosclerosis: What is the Evidence?, Current Atherosclerosis Reports, 2011, 13, 2, 123

    CrossRef

  55. 55
    Heather A. Hirsch, Dimitrios Iliopoulos, Amita Joshi, Yong Zhang, Savina A. Jaeger, Martha Bulyk, Philip N. Tsichlis, X. Shirley Liu, Kevin Struhl, A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human Diseases, Cancer Cell, 2010, 17, 4, 348

    CrossRef

  56. 56
    C. Kazda, L. Slieker, L. Ilag, R. Byrd, T. Rees, M. Prince, Appraising the mitogenicity of insulin analogues relative to human insulin—response to: Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activity in cultured cancer cells. Diabetes Metab Res Rev 2009; 25(1): 41–9, Diabetes/Metabolism Research and Reviews, 2010, 26, 3
    Direct Link:
  57. 57
    C. J. Wotton, D. G. R. Yeates, M. J. Goldacre, Cancer in patients admitted to hospital with diabetes mellitus aged 30 years and over: record linkage studies, Diabetologia, 2010, 54, 3, 527

    CrossRef

  58. 58
    Melanie Cebioglu, Hans H. Schild, Olga Golubnitschaja, Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures, The EPMA Journal, 2010, 1, 1, 130

    CrossRef

  59. 59
    T. A. Chowdhury, Diabetes and Cancer, QJM, 2010, 103, 12, 905

    CrossRef

  60. 60
    Michael G. Schrauder, Peter A. Fasching, Lothar Häberle, Michael P. Lux, Claudia Rauh, Alexander Hein, Christian M. Bayer, Katharina Heusinger, Arndt Hartmann, Johanna D. Strehl, David L. Wachter, Rüdiger Schulz-Wendtland, Boris Adamietz, Matthias W. Beckmann, Christian R. Loehberg, Diabetes and prognosis in a breast cancer cohort, Journal of Cancer Research and Clinical Oncology, 2010, 137, 6, 975

    CrossRef

  61. 61
    M. Shawn McFarland, Rebecca Cripps, Diabetes Mellitus and Increased Risk of Cancer: Focus on Metformin and the Insulin Analogs, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010, 30, 11
    Direct Link:
  62. 62
    Yu-Chung Huang, Jen-Kou Lin, Wei-Shone Chen, Tzu-Chen Lin, Shung-Haur Yang, Jeng-Kai Jiang, Shih-Ching Chang, Yuan-Tzu Lan, Huann-Sheng Wang, Chun-Yu Liu, Ya-Wen Yang, Hao-Wei Teng, Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease, Journal of Cancer Research and Clinical Oncology, 2010, 137, 2, 211

    CrossRef

  63. 63
    D. Simon, B. Balkau, Diabetes mellitus, hyperglycaemia and cancer, Diabetes & Metabolism, 2010, 36, 3, 182

    CrossRef

  64. 64
    Jose M. Miguel-Yanes, Diabetes, Insulin Resistance, and Cancer: An Update, Current Cardiovascular Risk Reports, 2010, 5, 1, 70

    CrossRef

  65. 65
    Maureen Sanderson, Gerson Peltz, Adriana Perez, Matthew Johnson, Sally W. Vernon, Maria E. Fernandez, Mary K. Fadden, Diabetes, physical activity and breast cancer among Hispanic women, Cancer Epidemiology, 2010, 34, 5, 556

    CrossRef

  66. 66
    X. H. Zhou, Q. Qiao, B. Zethelius, K. Pyörälä, S. Söderberg, A. Pajak, C. D. A. Stehouwer, R. J. Heine, P. Jousilahti, G. Ruotolo, P. M. Nilsson, G. Calori, J. Tuomilehto, Diabetes, prediabetes and cancer mortality, Diabetologia, 2010, 53, 9, 1867

    CrossRef

  67. 67
    C Algire, L Amrein, M Bazile, S David, M Zakikhani, M Pollak, Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo, Oncogene, 2010, 30, 10, 1174

    CrossRef

  68. 68
    Geum Youb Noh, Dae-Yong Hwang, Yoon Hee Choi, Yun Yong Lee, Effect of Diabetes Mellitus on Outcomes of Colorectal Cancer, Journal of the Korean Society of Coloproctology, 2010, 26, 6, 424

    CrossRef

  69. 69
    Antonio Nicolucci, Epidemiological aspects of neoplasms in diabetes, Acta Diabetologica, 2010, 47, 2, 87

    CrossRef

  70. 70
    S. L. Bowker, Y. Yasui, P. Veugelers, J. A. Johnson, Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure, Diabetologia, 2010, 53, 8, 1631

    CrossRef

  71. 71
    Howard S. Kim, Joseph C. Presti, William J. Aronson, Martha K. Terris, Christopher J. Kane, Christopher L. Amling, Stephen J. Freedland, Glycemic control and prostate cancer progression: Results from the SEARCH database, The Prostate, 2010, 70, 14
    Direct Link:
  72. 72
    Peter E. Clayton, Indraneel Banerjee, Philip G. Murray, Andrew G. Renehan, Growth hormone, the insulin-like growth factor axis, insulin and cancer risk, Nature Reviews Endocrinology, 2010, 7, 1, 11

    CrossRef

  73. 73
    Cheng-Hsien Wu, Tzu-Ying Wu, Chia-Chen Li, Man-Tin Lui, Kuo-Wei Chang, Shou-Yen Kao, Impact of Diabetes Mellitus on the Prognosis of Patients with Oral Squamous Cell Carcinoma: A Retrospective Cohort Study, Annals of Surgical Oncology, 2010, 17, 8, 2175

    CrossRef

  74. You have free access to this content74
    M. Pollak, D. Russell-Jones, Insulin analogues and cancer risk: cause for concern or cause célèbre?, International Journal of Clinical Practice, 2010, 64, 5
    Direct Link:
  75. 75
    Krystal L. Edwards, Daniel M. Riche, Jeffrey S. Stroup, Jennifer D. Goldman-Levine, Rosalyn S. Padiyara, L. Brian Cross, Michael P Kane, Insulin Glargine and Cancer Risk: An Opinion Statement of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2010, 30, 9
    Direct Link:
  76. 76
    Mehrshad Abbasi, Azam Tarafdari, Alireza Esteghamati, Kaveh Vejdani, Manouchehr Nakhjavani, Insulin Resistance and Breast Carcinogenesis: A Cross-Sectional Study Among Iranian Women with Breast Mass, Metabolic Syndrome and Related Disorders, 2010, 8, 5, 411

    CrossRef

  77. You have free access to this content77
    Shoichiro Tsugane, Manami Inoue, Insulin resistance and cancer: Epidemiological evidence, Cancer Science, 2010, 101, 5
    Direct Link:
  78. 78
    J. A. Johnson, S. L. Bowker, Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials, Diabetologia, 2010, 54, 1, 25

    CrossRef

  79. 79
    Mathilde Jalving, Jourik A. Gietema, Joop D. Lefrandt, Steven de Jong, Anna K.L. Reyners, Rijk O.B. Gans, Elisabeth G.E. de Vries, Metformin: Taking away the candy for cancer?, European Journal of Cancer, 2010, 46, 13, 2369

    CrossRef

  80. 80
    Sarah Nechuta, Nigel Paneth, Ellen M. Velie, Pregnancy characteristics and maternal breast cancer risk: a review of the epidemiologic literature, Cancer Causes & Control, 2010, 21, 7, 967

    CrossRef

  81. 81
    C. Jamin, Quelles hormones promeuvent le cancer du sein en post-ménopause : estrogènes, progestatifs, insuline et/ou adipocytokines ?, Gynécologie Obstétrique & Fertilité, 2010, 38, 1, 1

    CrossRef

  82. 82
    Christopher I. Li, Janet R. Daling, Mei-Tzu C. Tang, Kathleen E. Malone, Relationship between diabetes and risk of second primary contralateral breast cancer, Breast Cancer Research and Treatment, 2010, 125, 2, 545

    CrossRef

  83. 83
    Guanyu Wang, Singularity analysis of the AKT signaling pathway reveals connections between cancer and metabolic diseases, Physical Biology, 2010, 7, 4, 046015

    CrossRef

  84. 84
    Sang Yoon Park, Hyun Sil Kim, Nam Hee Kim, Suena Ji, So Young Cha, Jeong Gu Kang, Ichiro Ota, Keiji Shimada, Noboru Konishi, Hyung Wook Nam, Soon Won Hong, Won Ho Yang, Jürgen Roth, Jong In Yook, Jin Won Cho, Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition, The EMBO Journal, 2010, 29, 22, 3787

    CrossRef

  85. 85
    Hiroshi Noto, Keiichiro Osame, Takehiko Sasazuki, Mitsuhiko Noda, Substantially increased risk of cancer in patients with diabetes mellitus, Journal of Diabetes and its Complications, 2010, 24, 5, 345

    CrossRef

  86. 86
    Emily J. Gallagher, Yvonne Fierz, Rosalyn D. Ferguson, Derek LeRoith, The Pathway from Diabetes and Obesity to Cancer, on the Route to Targeted Therapy, Endocrine Practice, 2010, 16, 5, 864

    CrossRef

  87. 87
    Dara Cannata, Yvonne Fierz, Archana Vijayakumar, Derek LeRoith, Type 2 Diabetes and Cancer: What Is the Connection?, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010, 77, 2
    Direct Link:
  88. 88
    Paola Catanuto, Sophie Doublier, Enrico Lupia, Alessia Fornoni, Mariana Berho, Michael Karl, Gary E Striker, Xiaomei Xia, Sharon Elliot, 17 β-estradiol and tamoxifen upregulate estrogen receptor β expression and control podocyte signaling pathways in a model of type 2 diabetes, Kidney International, 2009, 75, 11, 1194

    CrossRef

  89. 89
    Susan Jordan, Lynette Lim, Duangkae Vilainerun, Emily Banks, Nintita Sripaiboonkij, Sam-ang Seubsman, Adrian Sleigh, Christopher Bain, Breast cancer in the Thai Cohort Study: An exploratory case-control analysis, The Breast, 2009, 18, 5, 299

    CrossRef

  90. You have free access to this content90
    Zachary Bloomgarden, Yehuda Handelsman, Cancer mortality and insulin glargine, Journal of Diabetes, 2009, 1, 3
    Direct Link:
  91. 91
    U. Smith, E. A. M. Gale, Does diabetes therapy influence the risk of cancer?, Diabetologia, 2009, 52, 9, 1699

    CrossRef

  92. 92
    Susanna C. Larsson, Leif Bergkvist, Alicja Wolk, Glycemic load, glycemic index and breast cancer risk in a prospective cohort of Swedish women, International Journal of Cancer, 2009, 125, 1
    Direct Link:
  93. 93
    Satish K. Garg, Irl B. Hirsch, Jay S. Skyler, Insulin Glargine and Cancer—An Unsubstantiated Allegation, Diabetes Technology & Therapeutics, 2009, 11, 8, 473

    CrossRef

  94. 94
    S. Sadikot, A. Sosale, A. Nigam, J. Ahmed, S. Singh, A. Zargar, A. Misra, K. PrasannaKumar, S. Wangnoo, B. Makker, S. Bajaj, J. Singh, U. Dhruv, M. Jali, N. Sinha, K. Sai, Y. SadasivRao, S. Murthy, A. Reddy, No “Barge in” on “Glargine”!, Diabetes and Metabolic Syndrome: Clinical Research and Reviews, 2009, 3, 3, 132

    CrossRef

  95. 95
    Susen Becker, Laure Dossus, Rudolf Kaaks, Obesity related hyperinsulinaemia and hyperglycaemia and cancer development, Archives Of Physiology And Biochemistry, 2009, 115, 2, 86

    CrossRef

  96. 96
    L. G. Hemkens, U. Grouven, R. Bender, C. Günster, S. Gutschmidt, G. W. Selke, P. T. Sawicki, Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study, Diabetologia, 2009, 52, 9, 1732

    CrossRef

  97. 97
    W.A. Scherbaum, Sicherheit von Insulin Glargin, Der Diabetologe, 2009, 5, 6, 416

    CrossRef

  98. 98
    C. J. Currie, C. D. Poole, E. A. M. Gale, The influence of glucose-lowering therapies on cancer risk in type 2 diabetes, Diabetologia, 2009, 52, 9, 1766

    CrossRef

  99. 99
    Stephen M. Sagar, Brian D. Lawenda, The role of integrative oncology in a tertiary prevention survivorship program, Preventive Medicine, 2009, 49, 2-3, 93

    CrossRef

  100. 100
    X. Ren, X. Zhang, X. Zhang, W. Gu, K. Chen, Y. Le, M. Lai, Y. Zhu, Type 2 diabetes mellitus associated with increased risk for colorectal cancer: Evidence from an international ecological study and population-based risk analysis in China, Public Health, 2009, 123, 8, 540

    CrossRef

  101. 101
    Xiaoping Lin, Qingsheng Wang, Application of meta-analysis in evidence-based oncology, Chinese Journal of Clinical Oncology, 2008, 5, 1, 1

    CrossRef

  102. 102
    Susanna C. Larsson, Swen-Olof Andersson, Jan-Erik Johansson, Alicja Wolk, Diabetes mellitus, body size and bladder cancer risk in a prospective study of Swedish men, European Journal of Cancer, 2008, 44, 17, 2655

    CrossRef

  103. 103
    H G Mulholland, L J Murray, C R Cardwell, M M Cantwell, Dietary glycaemic index, glycaemic load and breast cancer risk: a systematic review and meta-analysis, British Journal of Cancer, 2008, 99, 7, 1170

    CrossRef

  104. 104
    C. Pichard, G. Plu-Bureau, M. Neves-e Castro, A. Gompel, Insulin resistance, obesity and breast cancer risk, Maturitas, 2008, 60, 1, 19

    CrossRef

  105. 105
    Laure Dossus, Rudolf Kaaks, Nutrition, metabolic factors and cancer risk, Best Practice & Research Clinical Endocrinology & Metabolism, 2008, 22, 4, 551

    CrossRef

  106. 106
    Guixiang Zhao, Earl S. Ford, Indu B. Ahluwalia, Chaoyang Li, Ali H. Mokdad, Prevalence and Trends of Receipt of Cancer Screenings Among US Women with Diagnosed Diabetes, Journal of General Internal Medicine, 2008, 24, 2, 270

    CrossRef

  107. 107
    C.-H. Tseng, C.-K. Chong, T.-Y. Tai, Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006, Diabetologia, 2008, 52, 2, 240

    CrossRef

  108. 108
    Michelle D. Owens, Gloria L.A. Beckles, Karen Kar-Yee Ho, Paul Gorrell, Jeffrey Brady, Jackie Shakeh Kaftarian, Women with Diagnosed Diabetes across the Life Stages: Underuse of Recommended Preventive Care Services, Journal of Women's Health, 2008, 17, 9, 1415

    CrossRef

View Full Article (HTML) Get PDF (190K)